Jamie Perse
Stock Analyst at Goldman Sachs
(3.17)
# 1,173
Out of 5,053 analysts
67
Total ratings
54.76%
Success rate
11.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jamie Perse
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGL agilon health | Maintains: Neutral | $2.5 → $5 | $0.66 | +658.27% | 7 | May 8, 2025 | |
| THC Tenet Healthcare | Maintains: Neutral | $134 → $154 | $194.68 | -20.90% | 12 | May 5, 2025 | |
| LFST LifeStance Health Group | Upgrades: Buy | $10 | $6.42 | +55.76% | 7 | Dec 16, 2024 | |
| OPCH Option Care Health | Downgrades: Neutral | $38 → $27 | $28.20 | -4.24% | 3 | Nov 5, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $32 | $19.27 | +66.06% | 1 | Aug 19, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $21 → $18 | $33.58 | -46.40% | 3 | Aug 9, 2024 | |
| UHS Universal Health Services | Maintains: Buy | $200 → $229 | $222.64 | +2.86% | 16 | Jul 30, 2024 | |
| INNV InnovAge Holding | Maintains: Neutral | $8 → $7 | $5.07 | +38.18% | 5 | Feb 8, 2024 | |
| HCA HCA Healthcare | Downgrades: Neutral | n/a | $459.30 | - | 10 | Dec 11, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $13 | $7.94 | +63.73% | 2 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $23.40 | +36.75% | 1 | Feb 3, 2023 |
agilon health
May 8, 2025
Maintains: Neutral
Price Target: $2.5 → $5
Current: $0.66
Upside: +658.27%
Tenet Healthcare
May 5, 2025
Maintains: Neutral
Price Target: $134 → $154
Current: $194.68
Upside: -20.90%
LifeStance Health Group
Dec 16, 2024
Upgrades: Buy
Price Target: $10
Current: $6.42
Upside: +55.76%
Option Care Health
Nov 5, 2024
Downgrades: Neutral
Price Target: $38 → $27
Current: $28.20
Upside: -4.24%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $32
Current: $19.27
Upside: +66.06%
BrightSpring Health Services
Aug 9, 2024
Maintains: Buy
Price Target: $21 → $18
Current: $33.58
Upside: -46.40%
Universal Health Services
Jul 30, 2024
Maintains: Buy
Price Target: $200 → $229
Current: $222.64
Upside: +2.86%
InnovAge Holding
Feb 8, 2024
Maintains: Neutral
Price Target: $8 → $7
Current: $5.07
Upside: +38.18%
HCA Healthcare
Dec 11, 2023
Downgrades: Neutral
Price Target: n/a
Current: $459.30
Upside: -
Enhabit
Jul 17, 2023
Maintains: Neutral
Price Target: $15 → $13
Current: $7.94
Upside: +63.73%
Feb 3, 2023
Initiates: Buy
Price Target: $32
Current: $23.40
Upside: +36.75%